These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 25582271)
21. Blood group genotyping: from patient to high-throughput donor screening. Veldhuisen B; van der Schoot CE; de Haas M Vox Sang; 2009 Oct; 97(3):198-206. PubMed ID: 19548962 [TBL] [Abstract][Full Text] [Related]
22. Molecular typing of Kell, Kidd, and Duffy antigens in direct antiglobulin test-positive autoimmune hemolytic anemia patients. Sonker A; Dubey A; Mohan Y Asian J Transfus Sci; 2024; 18(1):56-61. PubMed ID: 39036688 [TBL] [Abstract][Full Text] [Related]
29. Considerations of red blood cell molecular testing in transfusion medicine. Svensson AM; Delaney M Expert Rev Mol Diagn; 2015; 15(11):1455-64. PubMed ID: 26367503 [TBL] [Abstract][Full Text] [Related]
30. Integration of red cell genotyping into the blood supply chain: a population-based study. Flegel WA; Gottschall JL; Denomme GA Lancet Haematol; 2015 Jul; 2(7):e282-9. PubMed ID: 26207259 [TBL] [Abstract][Full Text] [Related]
31. Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform. López M; Apraiz I; Rubia M; Piedrabuena M; Azkarate M; Veldhuisen B; Vesga MÁ; Van Der Schoot E; Puente F; Tejedor D Blood Transfus; 2018 Feb; 16(2):193-199. PubMed ID: 27893355 [TBL] [Abstract][Full Text] [Related]
32. [Results of antigenic typing of erythrocytes in a sample of the population of the district of Monza. I. Diallelic systems of erythrocytes: Kell, Lutheran, Duffy, Kidd, P]. Bestetti A; Cazzaniga G; Ripamonti M; Assali G Riv Emoter Immunoematol; 1985; 32(1):17-40. PubMed ID: 3909361 [No Abstract] [Full Text] [Related]
33. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. Papay P; Hackner K; Vogelsang H; Novacek G; Primas C; Reinisch W; Eser A; Mikulits A; Mayr WR; Körmöczi GF Am J Med; 2012 Jul; 125(7):717.e1-8. PubMed ID: 22560809 [TBL] [Abstract][Full Text] [Related]
34. Application of blood group genotyping in complex cases of immunohematology. Musial LB; Prochaska CL; Moss MF; Cruz BR Asian J Transfus Sci; 2023; 17(2):164-168. PubMed ID: 38274970 [TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Fully Automated Platform for Extended Blood Group Genotyping. Boccoz SA; Le Goff GC; Mandon CA; Corgier BP; Blum LJ; Marquette CA J Mol Diagn; 2016 Jan; 18(1):144-52. PubMed ID: 26621100 [TBL] [Abstract][Full Text] [Related]
37. When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature. Akinbolaji TJ Immunohematology; 2024 Jun; 40(2):58-64. PubMed ID: 38910442 [TBL] [Abstract][Full Text] [Related]
38. Frequency of red blood cell phenotypes from genotyped Australian blood donors. Jacko G; Powley T; Daly J Transfus Med; 2024 Jun; 34(3):219-222. PubMed ID: 38659102 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy. Haer-Wigman L; Ji Y; Lodén M; de Haas M; van der Schoot CE; Veldhuisen B Transfusion; 2013 Nov; 53(11 Suppl 2):2899-909. PubMed ID: 23992446 [TBL] [Abstract][Full Text] [Related]
40. The experience of extended blood group genotyping by next-generation sequencing (NGS): investigation of patients with sickle-cell disease. Fichou Y; Mariez M; Le Maréchal C; Férec C Vox Sang; 2016 Nov; 111(4):418-424. PubMed ID: 27442304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]